{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:54:53Z","timestamp":1780430093835,"version":"3.54.1"},"reference-count":33,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Women's Health"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To analyze insulin resistance (IR) and determine the need for a 2-hour oral glucose tolerance test (OGTT) for the identification of IR and impaired glucose tolerance (IGT) in lean nondiabetic women with polycystic ovary syndrome (PCOS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This was a cross-sectional analysis of treatment-naive women with PCOS who enrolled in a university-based clinical trial. Nondiabetic women with PCOS based on the Eunice Kennedy Shriven National Institute of Child Health and Human Development (NICHD) definition, aged 18\u201343 years and weighing \u2264113\u2009kg, were evaluated. Glucose and insulin levels were assessed at times 0, 30, 60, 90, and 120 minutes after a 75-g glucose load. Lean was defined as body mass index (BMI) &lt;25\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      . Multiple linear regression was performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A cohort of 78 women was studied. The prevalence of IR was 0% among lean women vs. 21% among nonlean subjects based on fasting insulin I\n                      <jats:sub>0<\/jats:sub>\n                      and 40%\u201368% based on two different homeostatic model assessment (HOMA) cutoff points (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.005). All women with IR had a BMI\u2009\u2265\u200928. Controlling for age and race, BMI explained over 57% of the variation in insulin fasting (I\n                      <jats:sub>o<\/jats:sub>\n                      ), glucose fasting\/Io (G\n                      <jats:sub>o<\/jats:sub>\n                      \/I\n                      <jats:sub>o<\/jats:sub>\n                      ), the qualitative insulin sensitivity check index (QUICKI), and HOMA and was a highly significant predictor of these outcomes (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Only 1 of 31 (3%) of the lean PCOS women had IGT based on a 2-hour OGTT, and no lean subjects had IGT based on their fasting blood glucose.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Diabetes mellitus, IGT, and IR are far less common in young lean women with PCOS compared with obese women with PCOS. These data imply that it is unnecessary to routinely perform either IR testing or 2-hour OGTT in lean women with PCOS; however, greater subject accumulation is needed to determine if OGTT is necessary in lean women with PCOS. BMI is highly predictive of both insulin and glucose levels in women with PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jwh.2010.2053","type":"journal-article","created":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T19:33:04Z","timestamp":1293823984000},"page":"37-43","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":52,"title":["Assessment of Insulin Resistance and Impaired Glucose Tolerance in Lean Women with Polycystic Ovary Syndrome"],"prefix":"10.1177","volume":"20","author":[{"given":"Dale William","family":"Stovall","sequence":"first","affiliation":[{"name":"The University of Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia Purser","family":"Bailey","sequence":"additional","affiliation":[{"name":"The University of Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Pastore","sequence":"additional","affiliation":[{"name":"The University of Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2011,1,1]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.38.9.1165"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032046"},{"key":"e_1_3_3_4_2","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion M","year":"2000","unstructured":"Asuncion M, , Calvo RM, , San Millan JL, , Sancho J, , Avila S, , Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab, 2000; 85:2434\u20132438.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_3_5_2","first-page":"377","volume-title":"The polycystic ovary syndrome","author":"Zawadzki J","year":"1992","unstructured":"Zawadzki J, , Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. Dunaif AGJ, , Haseltine F, , Merriam GR. The polycystic ovary syndrome. Cambridge: Blackwell Scientific, 1992; 377\u2013384."},{"key":"e_1_3_3_6_2","volume-title":"The polycystic ovary syndrome","author":"Dunaif A","year":"1992","unstructured":"Dunaif A, , Givens JR, , Haseltine F. The polycystic ovary syndrome. Cambridge: Blackwell Scientific, 1992."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)03111-4"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1549"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0b013e31802f3547"},{"key":"e_1_3_3_10_2","first-page":"19","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2003","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril, 2003; 81:19\u201326.","journal-title":"Fertil Steril"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.10.6079"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.6.9999"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(82)90038-3"},{"key":"e_1_3_3_14_2","unstructured":"ARUP Laboratories Lab Guide. www.aruplab.com\/guides\/clt\/tests\/clt_212b.htm. 2003 June 11."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70099-2"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(99)00116-3"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.7.6661"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116768"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.126650"},{"key":"e_1_3_3_21_2","first-page":"4426","article-title":"Insulin sensitivity and its measurement: Structural commonalities among the methods","volume":"85","author":"Radziuk J","year":"2000","unstructured":"Radziuk J. Insulin sensitivity and its measurement: Structural commonalities among the methods. J Clin Endocrinol Metab, 2000; 85:4426\u20134433.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.7.1183"},{"key":"e_1_3_3_23_2","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women","volume":"84","author":"Legro RS","year":"1999","unstructured":"Legro RS, , Kunselman AR, , Dodson WC, , Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J Clin Endocrinol Metab, 1999; 84:165\u2013169.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.9.1995"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.11.7880"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030219"},{"key":"e_1_3_3_27_2","first-page":"2694","article-title":"A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome","volume":"83","author":"Legro R","year":"1998","unstructured":"Legro R, , Finegood D, , Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 1998; 83:2694\u20132698.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.10.7952"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/09513590802173584"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.02.168"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-2-356"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.03.062"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03350784"}],"container-title":["Journal of Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jwh.2010.2053","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2010.2053","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2010.2053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:34:20Z","timestamp":1777656860000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jwh.2010.2053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1089\/jwh.2010.2053"],"URL":"https:\/\/doi.org\/10.1089\/jwh.2010.2053","relation":{},"ISSN":["1540-9996","1931-843X"],"issn-type":[{"value":"1540-9996","type":"print"},{"value":"1931-843X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}